Antoinette Wozniak, MD, FACP, FASCO, discusses optimizing the use of immunotherapy in patients with non–small cell lung cancer.
Antoinette Wozniak, MD, FACP, FASCO
Advertisement
Articles by Antoinette Wozniak, MD, FACP, FASCO
Antoinette Wozniak, MD, FACP, FASCO, discusses sequencing with immunotherapy and chemoradiation in select patients with stage III lung cancer.
Advertisement
Latest Updated Articles
Dr. Wozniak on Optimizing the Use of Immunotherapy in NSCLCPublished: March 30th 2021 | Updated:
Dr. Wozniak on Sequencing Immunotherapy in Lung CancerPublished: November 5th 2019 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
FDA Advises on Next Steps for Nogapendekin Alfa Inbakicept Plus BCG sBLA in BCG-Unresponsive Papillary NMIBC
3
Iberdomide Plus Daratumumab/Dexamethasone Displays High Response Rates in NDMM
4
Ixazomib-Based Regimens Expand Options in Relapsed/Refractory Multiple Myeloma
5